You must be registered to submit an abstract. The submission of abstracts to be considered for Oral Presentation (Oral or Poster) is open until 16 July 2021. Abstracts can be submitted for poster presentation only until 3 September 2021. Selections for oral presentation will be informed after reviewing mid of August.
Abstracts submission requires a title of maximal 150 characters and an abstract text of maximal 300 words. Abstracts will be shown in the conference program in a similar style, however, some editing is possible using HTML code (italic, bold, underline, super- or subscript). Pictures and graphics cannot be included in the abstract. Abstracts have to be assigned to a scientific session:
Scientific sessions
- Pluripotency and reprograming
- Somatic stem cells and development
- Hematopoietic stem cells
- Stem cells in diseases: cancer stem cells
- Stem cells in regenerative therapies
- Stem cells in regenerative therapies: mesenchymal stromal cells
- Stem cells in disease modeling and drug development
- Organoids: new models for diseases
- Computational stem cell biology
Poster awards ( Awards)
There will be four poster awards. The awardees will receive € 500. Authors are asked to be present at the poster award ceremony, which will take place on Friday, 8 October 2021.
Oral presentation
The first author of the abstract is intended to give the lecture. The talks will be 12 minutes long followed by 3 minutes discussion. Abstracts selected for oral presentation may in addition be shown as poster presentation to allow further discussion.
Poster presentation
In general abstracts are accepted for poster presentations.
However, abstracts can be rejected based on lack of scientific quality or for ethical or legal reasons.
Posters will be displayed during the whole meeting with virtual meeting rooms set aside at specific time slots.
Authors are asked to present their poster during the respective time slots.
Posters are presented with an online system. Technical help to set-up the posters will be provided beforehand.
If you have any questions do not hesitate to contact the GSCN office or the technical support.